
Financial Toxicity and Societal Costs of Cancer Care: Distinct Problems Require Distinct Solutions
Author(s) -
Peppercorn Jeffrey
Publication year - 2017
Publication title -
the oncologist
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.176
H-Index - 164
eISSN - 1549-490X
pISSN - 1083-7159
DOI - 10.1634/theoncologist.2016-0301
Subject(s) - formulary , medicine , government (linguistics) , payment , actuarial science , finance , health care , public economics , business , family medicine , economic growth , economics , philosophy , linguistics
Control of societal costs can be addressed through clinician education, value‐based guidelines and pathways, formulary restrictions, payment reform, and government regulatory decisions but should not be imposed on patients at the point of decision‐making in the cancer clinic.